CIK 0001326110
- Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 431979754
- Phone
- +1 844-696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-06-23 | Tajak Richard J. Chief Financial Officer | Shares withheld for taxes | −1,708 | $6.73 | $11K | 3,292 |
| 2016-06-23 | Tajak Richard J. Chief Financial Officer | Option exercise · Restricted Stock Units | −5,000 | 15,000 | ||
| 2016-05-26 | Thomas John C Director | Option exercise | +277,725 | $0.22 | $60K | 335,789 |
| 2016-05-26 | Thomas John C Director | Option exercise · Stock Option (right to buy) | −277,725 | 0 | ||
| 2016-05-23 | GORLIN STEVE Director | Option exercise | +324,012 | $0.22 | $70K | 729,725 |
| 2016-05-23 | GORLIN STEVE Director | Option exercise · Stock Option (right to buy) | −324,012 | 0 | ||
| 2016-05-13 | BLASZYK MICHAEL D Director | Grant or award | +50,000 | 50,000 | ||
| 2016-03-23 | Tajak Richard J. Chief Financial Officer | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2016-03-17 | Kusserow Richard Director | Option exercise | +15,429 | $0.22 | $3K | 370,300 |
| 2016-03-17 | Kusserow Richard Director | Option exercise · Stock Option (right to buy) | −15,429 | 0 | ||
| 2016-03-01 | Thomas John C Director | Gift | −16,000 | 58,064 | ||
| 2016-02-28 | Kusserow Richard Director | Option exercise | +15,429 | $0.22 | $3K | 354,871 |
| 2016-02-28 | Kusserow Richard Director | Option exercise · Stock Option (right to buy) | −15,429 | 15,429 | ||
| 2016-02-10 | POTTS JOHN T JR Director | Option exercise | +100,000 | $0.22 | $22K | 100,000 |
| 2016-02-10 | POTTS JOHN T JR Director | Option exercise · Stock Option (right to buy) | −100,000 | 270,300 | ||
| 2016-01-28 | Kusserow Richard Director | Option exercise | +92,581 | $0.22 | $20K | 339,442 |
| 2016-01-28 | Kusserow Richard Director | Option exercise · Stock Option (right to buy) | −92,581 | 30,858 | ||
| 2015-12-10 | Wilson Angela Chief Financial Officer | Purchase | +167 | $15.28 | $3K | 167 |
| 2015-12-10 | Wilson Angela Chief Financial Officer | Purchase | +76 | $15.31 | $1K | 243 |
| 2015-12-10 | Wilson Angela Chief Financial Officer | Purchase | +3,022 | $15.33 | $46K | 3,265 |
Page 23 of 24 · 472 trades